Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase
- PMID: 18402834
- PMCID: PMC2693891
- DOI: 10.1016/j.carpath.2007.12.013
Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase
Abstract
Background: There is growing recognition that oxidative stress plays a role in the pathogeneses of myocardial repair/remodeling following myocardial infarction (MI). Nicotinamide adenine denucleotide phosphate (NADPH) oxidase is a major source for cardiac reactive oxygen species production. Herein, we studied the importance of NADPH oxidase in development of cardiac oxidative stress and its induced molecular and cellular changes related to myocardial repair/remodeling.
Methods: MI was created by coronary artery ligation in C57/BL (wild type) and NADPH oxidase (gp91(phox)) knockout mice. Cardiac oxidative stress, inflammatory/fibrogenic responses, apoptosis, and hypertrophy were detected by in situ hybridization, immunohistochemistry, terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL), picrosirius red staining, and image analysis, respectively, at different stages post MI.
Results: In wild-type mice with MI, and compared to sham-operated animals, we observed significantly increased gp91(phox) and 3-nitrotyrosine, a marker of oxidative stress, in the infarcted myocardium; accumulated macrophages and myofibroblasts at the infarct site; abundant apoptotic myocytes primarily at border zones on Day 3; and numerous apoptotic inflammatory/myofibroblasts in the later stages. In addition, we detected significantly increased transforming growth factor beta1, tissue inhibitor of metalloprotease 2, and type 1 collagen gene expression; continuously increasing collagen volume in the infarcted myocardium; and hypertrophy in noninfarcted myocardium. Compared to wild-type mice with MI, we did not observe significant difference in infarct size/thickness, cardiac hypertrophy, myocyte apoptosis, inflammatory/fibrogenic responses, as well as cardiac oxidative stress in gp91(phox) knockout mice.
Conclusion: Our findings indicate that during NADPH oxidase deficiency, superoxide production can be compensated by other sources, which leads to cardiac oxidative stress and its related molecular/cellular events in the infarcted heart.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2693891/bin/nihms116167f7.gif)
Similar articles
-
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction.Hypertension. 2008 Feb;51(2):319-25. doi: 10.1161/HYPERTENSIONAHA.107.101980. Epub 2008 Jan 7. Hypertension. 2008. PMID: 18180403
-
Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress.Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2197-203. doi: 10.1152/ajpheart.91496.2007. Epub 2008 Mar 7. Am J Physiol Heart Circ Physiol. 2008. PMID: 18326795
-
Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats.Mol Cell Biochem. 2008 Oct;317(1-2):43-50. doi: 10.1007/s11010-008-9803-8. Epub 2008 Jun 26. Mol Cell Biochem. 2008. PMID: 18581202
-
Oxidative stress and cardiac repair/remodeling following infarction.Am J Med Sci. 2007 Sep;334(3):197-205. doi: 10.1097/MAJ.0b013e318157388f. Am J Med Sci. 2007. PMID: 17873534 Review.
-
The Pathophysiological Role of NOX2 in Hypertension and Organ Damage.High Blood Press Cardiovasc Prev. 2016 Dec;23(4):355-364. doi: 10.1007/s40292-016-0175-y. High Blood Press Cardiovasc Prev. 2016. PMID: 27915400 Review.
Cited by
-
The Complex Relationship between Hypoxia Signaling, Mitochondrial Dysfunction and Inflammation in Calcific Aortic Valve Disease: Insights from the Molecular Mechanisms to Therapeutic Approaches.Int J Mol Sci. 2023 Jul 5;24(13):11105. doi: 10.3390/ijms241311105. Int J Mol Sci. 2023. PMID: 37446282 Free PMC article. Review.
-
Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt/β-catenin signaling.J Cell Mol Med. 2021 Dec;25(24):11053-11062. doi: 10.1111/jcmm.17028. Epub 2021 Nov 16. J Cell Mol Med. 2021. PMID: 34786834 Free PMC article.
-
The protective effects of liguzinediol on congestive heart failure induced by myocardial infarction and its relative mechanism.Chin Med. 2020 Jun 15;15:63. doi: 10.1186/s13020-020-00345-7. eCollection 2020. Chin Med. 2020. PMID: 32549908 Free PMC article.
-
The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.Ann Transl Med. 2017 Aug;5(16):326. doi: 10.21037/atm.2017.06.27. Ann Transl Med. 2017. PMID: 28861423 Free PMC article. Review.
-
Oxidative stress promotes myocardial fibrosis by upregulating KCa3.1 channel expression in AGT-REN double transgenic hypertensive mice.Pflugers Arch. 2017 Sep;469(9):1061-1071. doi: 10.1007/s00424-017-1984-0. Epub 2017 Apr 28. Pflugers Arch. 2017. PMID: 28455747
References
-
- Olivetti G, Capasso JM, Meggs LG, Sonnenblick EH, Anversa P. Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. Circ Res. 1991;68:856–869. - PubMed
-
- Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395–403. - PubMed
-
- Ertl G, Frantz S. Healing after myocardial infarction. Cardiovasc Res. 2005;66:22–32. - PubMed
-
- Anversa P, Li P, Zhang X. Ischemic myocardial injury and ventricular remodeling. Cardiovasc Res. 1993;27:145–157. - PubMed
-
- Francis GS, Mcdonald K, Chu G, Cohn JN. Pathophysiologic aspects of end-stage heart failure. Am J Cardio. 1995;75:11A–16A. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical